Indoco Remedies Secures Critical EU GMP Certifications, Bolstering Global Manufacturing Credibility

Indoco Remedies Secures Critical EU GMP Certifications, Bolstering Global Manufacturing Credibility​

Indoco Remedies has received significant quality endorsements following successful inspections of its manufacturing plants across India. The company secured crucial European Union Good Manufacturing Practice (GMP) certification for its solid oral dosage facility in Goa. This achievement elevates the firm's standing in the global pharmaceutical supply chain.

The certification was granted by the Malta Medicines Authority after an inspection conducted from November 19 to November 24, 2025. This milestone confirms that Plant I complies with all Good Manufacturing Practice requirements set forth by the relevant European Commission Directive.

Expanding Global Quality Footprint​

The successful audits underscore Indoco Remedies' unwavering commitment to world-class quality systems. Managing Director Aditi Panandikar commented on the development, stating that compliance is a core value driving their operational structure.

This international approval reinforces the company’s dedication to supplying the highest standard of healthcare products to its worldwide customer base. The certifications provide robust assurance regarding the integrity and consistency of Indoco's manufacturing processes.

Dual Certifications Validate OSD Manufacturing Excellence​

The recent Goa certification is part of a broader series of quality achievements. Earlier this year, Indoco Remedies also secured EU GMP certification for another key facility in Himachal Pradesh.

Plant III, located in Baddi, received the necessary documentation from the German Health Authority (Berlin) earlier in 2026. The inspection at this location took place between April 22 and April 27, 2026. This additional accreditation confirms that this facility also meets the stringent requirements of the EC Directive for Oral Solid Dosage (OSD).

Impact on Industry Standing​

The dual GMP certifications significantly strengthen Indoco Remedies' market position in the pharmaceutical manufacturing sector. Operating plants compliant with EU standards opens up expanded opportunities within regulated international markets.

These quality endorsements are critical indicators for stakeholders, confirming the company’s adherence to global best practices. The sustained investment in compliance positions Indoco as a reliable partner committed to high-quality drug production internationally.